Analysis of the Effectiveness and Safety of Lenvatinib/bevacizumab Combined with PD-1/PD-L1 Inhibitors and GEMOX in the First-Line Treatment of Advanced Biliary Tract Carcinoma
Clinical and Experimental Medicine（2025）
Key words
Biliary tract cancer,Lenvatinib,Bevacizumab,Immunotherapy,Efficacy,Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined